Novo Nordisk A/S Class B OverviewNovo Nordisk A/S Class B Other Income Expense Net
Other Income/Expense Net for NONOF.
Quarterly Other Income/Expense
$2.55B
↑ 245.28% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$7.19B
↑ 379.6% YoY
Trailing 12 months ending Mar 31, 2026